KUPPUSAMY KARTHIK
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to KUPPUSAMY KARTHIK. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| DGX | SVP, Clinical Solutions | Award / Grant | 15 | $189.08 | $2,836 | Oct 21, 2025 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 123 | $175.91 | $21,637 | Aug 13, 2025 |
| DGX | SVP, Clinical Solutions | Option Exercise | 5,224 | $112.17 | $585,976 | Jul 30, 2025 |
| DGX | SVP, Clinical Solutions | L | 27 | $167.50 | $4,523 | Jul 21, 2025 |
| DGX | SVP, Clinical Solutions | L | 27 | $164.42 | $4,439 | Apr 21, 2025 |
| DGX | SVP, Clinical Solutions | Sale | 2,555 | $170.00 | $434,350 | Apr 2, 2025 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 992 | $173.74 | $172,350 | Mar 4, 2025 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 233 | $171.75 | $40,018 | Feb 26, 2025 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 287 | $169.71 | $48,707 | Feb 19, 2025 |
| DGX | SVP, Clinical Solutions | Award / Grant | 2,269 | — | — | Feb 12, 2025 |
| DGX | SVP, Clinical Solutions | L | 12 | $158.03 | $1,896 | Jan 29, 2025 |
| DGX | SVP, Clinical Solutions | Sale | 1,775 | $156.92 | $278,533 | Oct 28, 2024 |
| DGX | SVP, Clinical Solutions | L | 21 | $149.37 | $3,137 | Oct 21, 2024 |
| DGX | SVP, Clinical Solutions | Sale | 1,990 | $153.26 | $304,987 | Aug 28, 2024 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 74 | $149.46 | $11,060 | Aug 14, 2024 |
| DGX | SVP, Clinical Solutions | L | 31 | $146.97 | $4,556 | Jul 22, 2024 |
| DGX | SVP, Clinical Solutions | Sale | 1,760 | $140.00 | $246,400 | Apr 29, 2024 |
| DGX | SVP, Clinical Solutions | Award / Grant | 45 | $126.25 | $5,681 | Apr 22, 2024 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 205 | $126.36 | $25,904 | Feb 28, 2024 |
| DGX | SVP, Clinical Solutions | Award / Grant | 2,039 | $125.02 | $254,916 | Feb 23, 2024 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 102 | $125.02 | $12,752 | Feb 21, 2024 |
| DGX | SVP, Clinical Solutions | Award / Grant | 2,641 | — | — | Feb 14, 2024 |
| DGX | SVP, Clinical Solutions | Award / Grant | 29 | $129.33 | $3,751 | Jan 31, 2024 |
| DGX | SVP, Clinical Solutions | Award / Grant | 30 | $122.86 | $3,686 | Oct 23, 2023 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 74 | $135.23 | $10,007 | Aug 15, 2023 |
| DGX | SVP, Clinical Solutions | Award / Grant | 25 | $144.59 | $3,615 | Jul 25, 2023 |
| DGX | SVP, Clinical Solutions | L | 25 | $143.08 | $3,577 | Apr 24, 2023 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 583 | $147.86 | $86,202 | Mar 6, 2023 |
| DGX | SVP, Clinical Solutions | Tax Withholding | 65 | $140.69 | $9,145 | Mar 1, 2023 |
| DGX | SVP, Clinical Solutions | Award / Grant | 2,094 | — | — | Feb 23, 2023 |
| DGX | SVP, Clinical Solutions | L | 13 | $146.75 | $1,908 | Feb 1, 2023 |